Interpretation of the JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease.
- Author:
Zhi-Long MU
1
;
Fu-Yong JIAO
1
;
Kai-Sheng XIE
Author Information
1. Children's Hospital of Shaanxi Provincial People's Hospital/Diagnosis and Treatment Center of Kawasaki Disease of Shaanxi Province, Xi'an 710068, China.
- Publication Type:Journal Article
- MeSH:
Child;
Coronary Aneurysm;
Coronary Vessels;
Disease Progression;
Heart Diseases;
Humans;
Mucocutaneous Lymph Node Syndrome/therapy*
- From:
Chinese Journal of Contemporary Pediatrics
2021;23(3):213-220
- CountryChina
- Language:Chinese
-
Abstract:
Kawasaki disease is the main cause of acquired heart disease in children. The cardiovascular sequelae of Kawasaki disease, such as coronary artery lesion and giant coronary aneurysm, have a great impact on children's physical and mental health. The Japanese Circulatory Society and the Japanese Society of Cardiac Surgery jointly released the JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease in July, 2020, which systematically introduces the advances in the diagnosis and management of cardiovascular sequelae of Kawasaki disease. The article gives an interpretation in the severity evaluation of Kawasaki disease and diagnosis, treatment and long-term management of cardiovascular sequelae in the guideline.
